You should not use Incruse Ellipta if you are allergic to umeclidinium or have a severe allergy to milk proteins.
Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.
Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.
Before taking this medicine
You should not use Incruse Ellipta if you are allergic to umeclidinium, or if you have:
a severe allergy to milk proteins.
To make sure Incruse Ellipta is safe for you, tell your doctor if you have:
glaucoma;
heart disease;
an enlarged prostate; or
urination problems.
Tell your doctor if you are pregnant or breastfeeding.
Incruse Ellipta is not approved for use by anyone younger than 18 years old.
How should I use Incruse Ellipta?
Use Incruse Ellipta exactly as it was prescribed for you. Follow all directions on your prescription label and read all medication guides or instruction sheets.
Incruse Ellipta is a powder that comes with a special inhaler device preloaded with blister packs containing measured doses of the medicine. The device opens and loads a blister of powdered medicine each time you use the inhaler. Follow the patient instructions provided with the inhaler device.
The usual dose is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period.
Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD.
Do not stop using this medicine without your doctor's advice, even if you feel fine.
Do not try to clean or take apart the inhaler device. Always use the new inhaler device provided with your refill.
Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.
Throw the inhaler away 6 weeks after opening, or when the dose indicator shows a zero (whichever comes first).
